Ignite Creation Date:
2024-05-06 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05938829
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-07-11
First Post:
2023-06-20
Brief Title:
Fetal Growth Restriction Management Using Two Guidelines - Fetal Growth Antenatal Management Evaluation
Sponsor:
The University of Texas Health Science Center Houston
Organization:
The University of Texas Health Science Center Houston
Study Overview
Official Title:
Fetal Growth Restriction Management Using Two Guidelines FAME - Fetal Growth Antenatal Management Evaluation
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FAME
Brief Summary:
The purpose of this study is to compare the composite neonatal adverse outcomes CNAO among pregnancies complicated by fetal growth restriction FGR managed using the Society of Maternal-Fetal Medicine SMFM versus International Society of Ultrasound in Obstetrics and Gynecology ISUOG antepartum ultrasound guidelines to measure the rate of the individual components of CNAO to record the rate of cesarean delivery during labor to tabulate the rate of deviation from the management protocol assigned at the time of evaluation to record neonatal intensive care unit NICU admission rates and to measure the rate of the composite maternal adverse outcome CMAO
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None